FINancial Toxicity and CAncer REcovery in YOUNG Adults

N/AEnrolling By InvitationNCT07314801

University Medical Center Goettingen300 enrolled

Overview

The FINCARE-Young study aims to investigate the extent and development of financial toxicity in adolescents and young adults with cancer. The primary purpose of this study is to assess the level of financial burden experienced during the acute phase of cancer treatment and after completion of therapy, and to analyze changes over time. In addition, the study seeks to identify sociodemographic, clinical, and socioeconomic factors associated with financial toxicity, as well as its impact on employment and social reintegration. By focusing on young adult cancer survivors, this study addresses an underexplored population and seeks to generate evidence to improve supportive care strategies and reduce long-term financial consequences of cancer.

Study Type

OBSERVATIONAL

Enrollment

300

Conditions

Financial Toxicity Related to Cancer Diagnosis and Tretment in Adolescents and Young Adults

Eligibility

Sex: ALLMin age: 18 YearsMax age: 50 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age 18 to 39 years at the time of initial cancer diagnosis * Diagnosis of a malignant neoplasm * Receipt of oncological treatment at the University Medical Center Göttingen * Completion of primary cancer therapy at the time of study participation * Initial diagnosis between 2014 and 2024 * Ability to provide informed consent * Sufficient German language skills to participate in a telephone interview and complete questionnaires Exclusion Criteria: * Age below 18 years or above 39 years at the time of initial cancer diagnosis * No history of malignant disease * Ongoing primary cancer treatment at the time of study participation * Severe cognitive impairment or psychiatric condition preventing reliable participation * Insufficient German language proficiency to complete interviews or questionnaires * Withdrawal of informed consent

Outcomes

Primary Outcomes

Financial toxicity

Financial toxicity, assessed using the Comprehensive Score for Financial Toxicity (COST) questionnaire, measured during the acute phase of cancer treatment and at the time of study participation, including change over time.

Time frame: From the acute phase of cancer treatment to the time of study participation after completion of therapy (retrospective assessment of treatment period and current assessment at follow-up), assessed only at one time point at study enrollment.